Abingworth’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

Abingworth’s Portfolio TBRA Stock Details TBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-589,244	Closed	-$7.38M	–	21
2016 Q2	$7.38M	Hold	589,244	–	–	7.72%	4
2016 Q1	$4.79M	Hold	589,244	–	–	4.45%	7
2015 Q4	$5.9M	Hold	589,244	–	–	3.56%	7
2015 Q3	$5.66M	Hold	589,244	–	–	3.3%	9
2015 Q2	$10.2M	Buy	+589,244	New	+$8.62M	4.61%	8

Other funds holding TBRA

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Abingworth's TBRA Position: Q3 2016 in Review

Abingworth sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q3 2016, closing a stake of 589,244 shares — an estimated $7.38M sold.

Abingworth first reported a position in TBRA in Q2 2015 and held it in 5 quarters. The position peaked at $10.2M in Q2 2015. 68 funds tracked by Wall St. Rank hold TBRA as of Q3 2016.

Abingworth reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q3 2016 after selling out during the quarter.
Abingworth sold 589,244 Tobira Therapeutics, Inc. Common Stock shares in Q3 2016, an estimated $7.38M.
Abingworth first reported a position in Tobira Therapeutics, Inc. Common Stock in Q2 2015 and held it in 5 quarters.
Abingworth's Tobira Therapeutics, Inc. Common Stock position peaked at $10.2M in Q2 2015.
68 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q3 2016.

Based on Abingworth's 13F filing for Q3 2016, filed 14 Nov 2016.